ES2071986T3 - Enmascaramiento del sabor del ibuprofeno con revestimiento en lecho fluidificado. - Google Patents

Enmascaramiento del sabor del ibuprofeno con revestimiento en lecho fluidificado.

Info

Publication number
ES2071986T3
ES2071986T3 ES91904188T ES91904188T ES2071986T3 ES 2071986 T3 ES2071986 T3 ES 2071986T3 ES 91904188 T ES91904188 T ES 91904188T ES 91904188 T ES91904188 T ES 91904188T ES 2071986 T3 ES2071986 T3 ES 2071986T3
Authority
ES
Spain
Prior art keywords
ibuprophen
masking
flavor
bed coating
fluidified bed
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES91904188T
Other languages
English (en)
Inventor
Robert Wu-Wei Shen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pharmacia and Upjohn Co
Original Assignee
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Upjohn Co filed Critical Upjohn Co
Application granted granted Critical
Publication of ES2071986T3 publication Critical patent/ES2071986T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Nutrition Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Physiology (AREA)
  • Rheumatology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

UNA PASTILLA DE IBUPROFENO ENMASCARADA CON AROMA, MASTICABLE QUE TIENE UNAS CARACTERISTICAS DE LIBERACION CONTROLADA.
ES91904188T 1990-04-11 1991-02-26 Enmascaramiento del sabor del ibuprofeno con revestimiento en lecho fluidificado. Expired - Lifetime ES2071986T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US50819390A 1990-04-11 1990-04-11

Publications (1)

Publication Number Publication Date
ES2071986T3 true ES2071986T3 (es) 1995-07-01

Family

ID=24021750

Family Applications (1)

Application Number Title Priority Date Filing Date
ES91904188T Expired - Lifetime ES2071986T3 (es) 1990-04-11 1991-02-26 Enmascaramiento del sabor del ibuprofeno con revestimiento en lecho fluidificado.

Country Status (14)

Country Link
US (1) US5552152A (es)
EP (1) EP0524180B1 (es)
JP (1) JPH05506011A (es)
AT (1) ATE121619T1 (es)
AU (1) AU639988B2 (es)
CA (1) CA2076983A1 (es)
DE (1) DE69109282T2 (es)
DK (1) DK0524180T3 (es)
ES (1) ES2071986T3 (es)
FI (1) FI924589A (es)
HU (2) HUT64220A (es)
NO (1) NO300758B1 (es)
RU (1) RU2101010C1 (es)
WO (1) WO1991015194A1 (es)

Families Citing this family (49)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19648576C2 (de) * 1996-11-23 1999-08-12 Lohmann Therapie Syst Lts Lutschtablette zur modifizierten Freisetzung von Wirkstoffen im Gastrointestinaltrakt
FR2766089B1 (fr) * 1997-07-21 2000-06-02 Prographarm Lab Comprime multiparticulaire perfectionne a delitement rapide
ATE213246T1 (de) * 1997-11-12 2002-02-15 2-phenyl-substituierte imidazotriazinone als phosphodiesterase inhibitoren
FR2785539B1 (fr) 1998-11-06 2004-04-09 Prographarm Laboratoires Particules enrobees d'ibuprofene cristallin granule
FR2785538B1 (fr) * 1998-11-06 2004-04-09 Prographarm Laboratoires Comprime a delitement rapide perfectionne
US6270807B1 (en) 1999-03-02 2001-08-07 L. Perrigo Company Taste-masked pharmaceutical composition
BR0009557A (pt) 1999-04-06 2002-05-28 Ethypharm Lab Prod Ethiques Suspensão farmacêutica para beber de ibuprofeno
AU765526B2 (en) 1999-08-17 2003-09-18 Novartis Consumer Health S.A. Rapidly dissolving dosage form and process for making same
RU2246294C2 (ru) 1999-12-09 2005-02-20 Дзе Бутс Компани ПЛС Терапевтические средства
US6551617B1 (en) 2000-04-20 2003-04-22 Bristol-Myers Squibb Company Taste masking coating composition
ATE361061T1 (de) 2000-04-20 2007-05-15 Novartis Ag Beschichtungszusammensetzung zur geschmacksmaskierung
WO2002089808A1 (de) * 2001-05-09 2002-11-14 Bayer Healthcare Ag Neue verwendung von 2-phenyl-substituierten imidazotriazinonen
PT1411899E (pt) * 2001-08-01 2009-04-24 Novartis Ag Composição de mascaramento de sabor
US11207805B2 (en) 2001-10-12 2021-12-28 Aquestive Therapeutics, Inc. Process for manufacturing a resulting pharmaceutical film
US8765167B2 (en) 2001-10-12 2014-07-01 Monosol Rx, Llc Uniform films for rapid-dissolve dosage form incorporating anti-tacking compositions
US7357891B2 (en) 2001-10-12 2008-04-15 Monosol Rx, Llc Process for making an ingestible film
US20190328679A1 (en) 2001-10-12 2019-10-31 Aquestive Therapeutics, Inc. Uniform films for rapid-dissolve dosage form incorporating anti-tacking compositions
US20110033542A1 (en) 2009-08-07 2011-02-10 Monosol Rx, Llc Sublingual and buccal film compositions
US8603514B2 (en) 2002-04-11 2013-12-10 Monosol Rx, Llc Uniform films for rapid dissolve dosage form incorporating taste-masking compositions
US10285910B2 (en) 2001-10-12 2019-05-14 Aquestive Therapeutics, Inc. Sublingual and buccal film compositions
ATE536173T1 (de) 2002-02-21 2011-12-15 Biovail Lab Int Srl Formulierungen mit modifizierter freisetzung von mindestens einer form von tramadol
CO5400144A1 (es) * 2002-03-11 2004-05-31 Novartis Ag Compuestos organicos
DE10232113A1 (de) * 2002-07-16 2004-01-29 Bayer Ag Vardenafil Hydrochlorid Trihydrat enthaltende Arzneimittel
FR2850275B1 (fr) 2003-01-24 2005-04-08 Scherer Technologies Inc R P Capsules molles a macher contenant une substance active a gout masque
JP2007031281A (ja) * 2003-06-25 2007-02-08 Kowa Co イブプロフェン含有フィルムコーティング錠剤
US20050220825A1 (en) * 2004-03-10 2005-10-06 Adrian Funke Molecular dispersions of drospirenone
DE102004023069A1 (de) * 2004-05-11 2005-12-08 Bayer Healthcare Ag Neue Darreichungsformen des PDE 5-Inhibitors Vardenafil
DE102005001989A1 (de) * 2005-01-15 2006-07-20 Bayer Healthcare Ag Intravenöse Formulierungen von PDE-Inhibitoren
DE102005009241A1 (de) * 2005-03-01 2006-09-07 Bayer Healthcare Ag Arzneiformen mit kontrollierter Bioverfügbarkeit
DE102005009240A1 (de) * 2005-03-01 2006-09-07 Bayer Healthcare Ag Arzneiformen mit verbesserten pharmakokinetischen Eigenschaften
KR20080056250A (ko) * 2005-09-29 2008-06-20 바이엘 헬스케어 아게 비뇨기 장애의 치료를 위한 ｐｄｅ 억제제 및 이들의 조합
US20070134493A1 (en) * 2005-12-08 2007-06-14 Kanji Meghpara Compositions and capsules with stable hydrophilic layers
US7767248B2 (en) 2007-02-02 2010-08-03 Overly Iii Harry J Soft chew confectionary with high fiber and sugar content and method for making same
WO2008151734A1 (en) * 2007-06-13 2008-12-18 Bayer Schering Pharma Aktiengesellschaft Pde inhibitors for the treatment of hearing impairment
US8404275B2 (en) 2007-07-01 2013-03-26 Vitalis Llc Combination tablet with chewable outer layer
CA2690956C (en) * 2007-07-01 2017-01-03 Joseph Peter Habboushe Combination tablet with chewable outer layer
ES2363964B1 (es) 2009-11-20 2012-08-22 Gp Pharm, S.A. Cápsulas de principios activos farmacéuticos y ésteres de ácidos grasos poliinsaturados.
US9149959B2 (en) 2010-10-22 2015-10-06 Monosol Rx, Llc Manufacturing of small film strips
WO2013063078A1 (en) 2011-10-28 2013-05-02 Vitalis Llc Anti-flush compositions
DK2833880T3 (en) * 2012-04-02 2017-12-04 Pharma Seeds Create Llc Oral solid dosage composition with ibuprofen comprising a methacrylic acid copolymer
US8993041B2 (en) 2012-10-15 2015-03-31 New Jersey Institute Of Technology Taste masked active pharmaceutical powder compositions and processes for making them
WO2014194872A1 (en) 2013-06-04 2014-12-11 Zentiva, K.S. Taste masking of water soluble drugs using poloxamers
RU2576236C1 (ru) * 2014-08-22 2016-02-27 Александр Александрович Кролевец Способ получения нанокапсул антибиотиков в агар-агаре
RU2577689C1 (ru) * 2014-08-26 2016-03-20 Александр Александрович Кролевец Способ получения нанокапсул антибиотиков в агар-агаре
RU2578408C1 (ru) * 2014-09-10 2016-03-27 Александр Александрович Кролевец Способ получения нанокапсул алкалоидов
BR112018072539A2 (pt) 2016-05-05 2019-03-26 Aquestive Therapeutics, Inc. composições de epinefrina de administração aumentada
US11273131B2 (en) 2016-05-05 2022-03-15 Aquestive Therapeutics, Inc. Pharmaceutical compositions with enhanced permeation
RU2688148C1 (ru) * 2016-05-10 2019-05-20 Александр Александрович Кролевец Способ получения нанокапсул экоцида в каррагинане
CN110917165A (zh) * 2019-12-26 2020-03-27 北京鑫开元医药科技有限公司海南分公司 一种布洛芬口崩片及其制备方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB971700A (en) * 1961-02-02 1964-09-30 Boots Pure Drug Co Ltd Anti-Inflammatory Agents
US4476248A (en) * 1983-02-28 1984-10-09 The Upjohn Company Crystallization of ibuprofen
US4609675A (en) * 1984-08-17 1986-09-02 The Upjohn Company Stable, high dose, high bulk density ibuprofen granulations for tablet and capsule manufacturing
DE3678644D1 (de) * 1985-08-16 1991-05-16 Procter & Gamble Wirkstoffpartikel mit sowohl kontinuierlicher als auch schneller freisetzung.
IT1214629B (it) * 1985-08-29 1990-01-18 Formenti Farmaceutici Spa Procedimento di microincapsulazione di un medicamento,medicamento cosi'preparato,e composizioni farmaceutiche che lo comprendono
US4800087A (en) * 1986-11-24 1989-01-24 Mehta Atul M Taste-masked pharmaceutical compositions
US4835186A (en) * 1987-06-15 1989-05-30 American Home Products Corporation Spray dried ibuprofen
US5084278A (en) * 1989-06-02 1992-01-28 Nortec Development Associates, Inc. Taste-masked pharmaceutical compositions

Also Published As

Publication number Publication date
AU7256091A (en) 1991-10-30
NO923947L (no) 1992-10-09
FI924589A0 (fi) 1992-10-09
NO300758B1 (no) 1997-07-21
ATE121619T1 (de) 1995-05-15
DE69109282D1 (de) 1995-06-01
DK0524180T3 (da) 1995-09-04
NO923947D0 (no) 1992-10-09
FI924589A (fi) 1992-10-09
EP0524180B1 (en) 1995-04-26
AU639988B2 (en) 1993-08-12
US5552152A (en) 1996-09-03
HU211247A9 (en) 1995-11-28
HUT64220A (en) 1993-12-28
JPH05506011A (ja) 1993-09-02
RU2101010C1 (ru) 1998-01-10
HU9203193D0 (en) 1992-12-28
WO1991015194A1 (en) 1991-10-17
CA2076983A1 (en) 1991-10-12
DE69109282T2 (de) 1995-09-28
EP0524180A1 (en) 1993-01-27

Similar Documents

Publication Publication Date Title
ES2071986T3 (es) Enmascaramiento del sabor del ibuprofeno con revestimiento en lecho fluidificado.
ES275176Y (es) Aparato conector para la union, con aplicacion de antiseptico, de los extremos de un par de conductos separados.
ES2119762T3 (es) Tratamiento de la catarata con la ayuda de derivados 15-ceto-prostaglandinas.
NO882123D0 (no) Maskering for antibiotikum.
NO905125D0 (no) Administrerings-innretning.
DE3863846D1 (de) Absorbierender artikel.
NO820255L (no) Terapeutisk nyttige tetralin-derivater.
NL7604090A (nl) Zelfborgende schroefdraad.
MX9205981A (es) Administracion transdermica de melatonina.
FI901443A0 (fi) Sammansaettningar och lokala foerfarande foer forming av en film pao kropps vaevande.
IT8821543A0 (it) Farmaci precursori della dopamina.
ES514766A0 (es) Procedimiento para la produccion de un alcaloide peptidico ciclico del 9'-tia-cornezuelo de centeno.
FR2385398B1 (es)
FI882401A (fi) Foerfarande och anordning foer formande av en torraemnesbana pao en vira.
MX9202890A (es) Procedimiento para la produccion de un lapiz.
DE3887225T2 (de) Beregnungsvorrichtung.
DE69022251T2 (de) Niedrigdosiertes Aspirin mit gesteuerter Freigabe.
IT8320840A0 (it) Preparazioni farmaceutiche con azione citostatica.
SE8802040D0 (sv) New use
FR1504117A (fr) Lit, notamment lit d'hôpital
IT213077Z2 (it) Dispositivo sanitario del microtelefono.
IT8722786V0 (it) Dispositivo sanitario del microtelefono.
ES1011690Y (es) Dispositivo para la administracion de enemas.
ES2096081T3 (es) Utilizacion de interleuquina 10 para la preparacion de medicamentos con una actividad inhibidora de tumores.
NO885682L (no) Fremgangsmaate for fremstilling av farmasoeytiske produktermed langvarig frigivende virkning.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 524180

Country of ref document: ES